植入式心律转复除颤器患者房性心律失常:内外电复律随机对照试验
该多中心随机试验将230例因房性心律失常行择期电复律的ICD患者1:1分配至体外或体内电复律,体外组转复窦律成功率93%高于体内组65%(P<0.001),两组均无临床相关不良事件,体内电复律揭示3例原有隐匿性导线故障。
要点
- 体外电复律转复窦律成功率显著高于体内电复律(93% vs 65%,P<0.001)。
- 两组均未观察到临床相关不良事件,肌钙蛋白释放无差异。
- 体内电复律暴露3例原有隐匿性导线故障,提示选择性患者可尝试体内电击。
核心结论
- 对于ICD患者房性心律失常电复律,体外电复律在恢复窦律方面优于体内电复律。
- 体内电复律可揭示隐匿性导线故障,在部分选择性ICD患者中尝试体内电击可能合理。
研究设计与样本
- 多中心随机临床试验,13个中心连续入选因房性心律失常行择期电复律的ICD患者。
- 共随机230例,按1:1分配至体内电复律组或体外电复律组。
主要发现
- 体外电复律组电击成功率为93%,体内电复律组为65%(P<0.001)。
- 未观察到由体外或体内电复律引起的临床相关不良事件。
- 体内电击揭示3例原有隐匿性导线故障,导致导线失效。
- 两组肌钙蛋白释放无差异。
关键数值与推荐
- 主要安全终点为导线或装置故障的替代事件复合终点。
- 主要疗效终点为房性心律失常转复为窦性心律。
临床怎么用
- ICD患者房性心律失常电复律时,优先考虑体外电复律以提高窦律恢复成功率。
- 在选择性ICD患者中,可考虑尝试体内电击以排查隐匿性导线故障。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atrial arrhythmias are common in patients with implantable cardioverter-defibrillator (ICD). External shocks and internal cardioversion through commanded ICD shock for electrical cardioversion are used for rhythm-control. However, there is a paucity of data on efficacy of external versus internal cardioversion and on the risk of lead and device malfunction. We hypothesized that external cardioversion is noninferior to internal cardioversion for safety, and superior for successful restoration of sinus rhythm. METHODS: Consecutive patients with ICD undergoing elective cardioversion for atrial arrhythmias at 13 centers were randomized in 1:1 fashion to either internal or external cardioversion. The primary safety end point was a composite of surrogate events of lead or device malfunction. Conversion of atrial arrhythmia to sinus rhythm was the primary efficacy end point. Myocardial damage was studied by measuring troponin release in both groups. RESULTS: N=230 patients were randomized. Shock efficacy was 93% in the external cardioversion group and 65% in the internal cardioversion group (P<0.001). Clinically relevant adverse events caused by external or internal cardioversion were not observed. Three cases of pre-existing silent lead malfunction were unmasked by internal shock, resulting in lead failure. Troponin release did not differ between groups. CONCLUSIONS: This is the first randomized trial on external vs internal cardioversion in patients with ICDs. External cardioversion was superior for the restoration of sinus rhythm. The unmasking of silent lead malfunction in the internal cardioversion group suggests that an internal shock attempt may be reasonable in selected ICD patients presenting for electrical cardioversion. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT03247738.
引用
- Lüker J, Kuhr K, Sultan A, et al. Internal Versus External Electrical Cardioversion of Atrial Arrhythmia in Patients With Implantable Cardioverter-Defibrillator: A Randomized Clinical Trial. Circulation. 2019. PMID: 31466479. doi:10.1161/CIRCULATIONAHA.119.041320
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。